1 |
K. L. Stanhope & P. J. Havel. (2008). Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Current opinion in lipidology, 19(1), 16-24. DOI: 10.1097/ MOL.0b013e3282f2b24a
DOI
|
2 |
K. N. Maxwell, R. E. Soccio, E. M. Duncan, E. Sehayek & J. L. Breslow. (2003). Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice. Journal of Lipid Research, 44(11), 2109-2119. DOI: 10.1194/jlr.M300203- JLR200
DOI
|
3 |
R. J. Mason, T. Pan, K. E. Edeen, L. D. Nielsen, F. Zhang, M. Longphre, M. R. Eckart & S. Neben. (2003). Keratinocyte growth factor and the transcription factors C/EBP alpha, C/EBP delta, and SREBP-1c regulate fatty acid synthesis in alveolar type II cells. Journal of Clinical Investigation, 112(2), 244-255. DOI: 10.1172/JCI16793
DOI
|
4 |
Y. Chang, K. Edeen, X. Lu, M. De Leon & R. J. Mason. (2006). Keratinocyte growth factor induces lipogenesis in alveolar type II cells through a sterol regulatory element binding protein-1c-dependent pathway. American Journal of Respiratory Cell and Molecular Biology, 35(2), 268-274. DOI: 10.1165/rcmb.2006-0037OC
DOI
|
5 |
J. S. Millar, S. J. Stone, U. J. Tietge, B. Tow, J. T. Billheimer, J. S. Wong, R. L. Hamilton, R. V. JR. Farese & D. J. Rader. (2006). Short-term overexpression of DGAT1 or DGAT2 increases hepatic triglyceride but not VLDL triglyceride or apoB production. J Lipid Res, 47(10), 2297-2305. DOI: 10.1194/jlr.M600213 -JLR200
DOI
|
6 |
G. V. Richieri, R. T. Ogata & A. M. Kleinfeld. (1994). Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB. The Journal of Biological Chemistry, 269(39), 23918-23930. PMID: 7929039
DOI
|
7 |
A. Reese-wagoner, J. Thompson & L. Banaszak. (1999). Structural properties of the adipocyte lipid binding protein. Biochimca et Biophysica Acta, 1441(2-3), 106-116. DOI: 10.1016/S1388-1981(99)00154-7
DOI
|
8 |
J. Thompson, J. Ory, A. Reese-wagoner & L. Banaszak. (1999a). The liver fatty acid binding protein-comparison of cavity properties of intracellular lipid-binding proteins. Molecular and Cellular Biochemistry, 192(1-2), 9-16. PMID: 10331654
DOI
|
9 |
J. Thompson, A. Reese-wagoner & L. Banaszak. (1999b). Liver fatty acid binding protein: species variation and the accommodation of different ligands. Biochimca et Biophysica Acta 1441(2-3), 117-130. DOI: 10.1016/s1388-1981(99) 00146-8
DOI
|
10 |
X. X. Yu, S. F. Murray, S. K. Pandey, S. L. Booten, D. Bao, X. Z. Song, S. Kelly, S. Chen, R. Mckay, B. P. Monia & S. Bhanot. (2005). Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice. Hepatology, 42(2), 362-371. DOI: 10.1002/hep.20783
DOI
|
11 |
W. C. Man, M. Miyazaki, K. Chu & J. Ntambi. (2006). Colocalization of SCD1 and DGAT2: implying preference for endogenous monounsaturated fatty acids in triglyceride synthesis. Journal of Lipid Research, 47(9), 1928-1939. DOI: 10.1194/jlr.M600172-JLR200
DOI
|
12 |
H. A. Coller, C. Grandori, P. Tamayo, T. Colbert, E. S. Lander, R. N. Eisenman & T. R. Golub. (2000). Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proceedings of the National Academy of Science of United State of America, 97(7), 3260-3265. DOI: 10.1073/pnas.97.7.3260
DOI
|
13 |
M. Furuhashi & G. S. Hotamisligil. (2008). Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nature Reviews Drug Discovery 7(6), 489-503. DOI: 10.1038/ nrd2589
DOI
|
14 |
L. Makowski & G. S. Hotamisligil. (2005). The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis. Current opinion in lipidology 16(5), 543-548. PMID: 16148539
DOI
|
15 |
J. Storch & A. E. Thumser. (2000). The fatty acid transport function of fatty acid-binding proteins. Biochimca et Biophysica Acta, 1486(1), 28-44. DOI: 10.1016/s1388-1981(00)00046-9
DOI
|
16 |
K. T. Hsu & J. Storch. (1996). Fatty acid transfer from liver and intestinal fatty acid-binding proteins to membranes occurs by different mechanisms. The Journal of Biological Chemistry, 271(23), 13317-13323. DOI: 10.1074/ jbc.271.23.13317
DOI
|
17 |
H. Y. Koo, M. A. Wallig, B. H. Chung, T. Y. Nara, B. H. Cho & M. T. Nakamura. (2008). Dietary fructose induces a wide range of genes with distinct shift in carbohydrate and lipid metabolism in fed and fasted rat liver. Biochimica et Biophysica Acta, 1782(5), 341-348. DOI: 10.1016/j.bbadis.2008.02.007
DOI
|
18 |
H. Yamashita, M. Takenoshita, M. Sakurai, R. K. Bruick, W. J. Henzel, W. Shillinglaw, D. Arnot & K. Uyeda. (2001). A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proceedings of the National Academy of Science of United State of America, 98(16), 9116-9121. DOI: 10.1073/pnas.161284298
DOI
|
19 |
L. Ma, L. N. Robinson & H. C. Towle. (2006). ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver. The Journal of Biological Chemistry, 281(39), 28721-28730. DOI: 10.1074/jbc.M601576200
DOI
|
20 |
M. Munz, R. Zeidler & O. Gires. (2005). The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP. Cancer Lett, 225(1), 151-157. DOI: 10.1016/j.canlet.2004. 11.048
DOI
|
21 |
N. H. Haunerland & F. Spener. (2004). Fatty acid-binding proteins--insights from genetic manipulations. Progress in Lipid Research, 43(4), 328-349. DOI: 10.1016/j.plipres.2004.05.001
DOI
|
22 |
E. P. Newberry, Y. Xie, S. M. Kennedy, J. Luo & N. O. Davidson. (2006). Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Hepatology, 44(5), 1191-1205. DOI: 10.1002/hep.21369
DOI
|
23 |
E. P. Newberry, S. M. Kennedy, Y. Xie, B. T. Sternard, J. Luo & N. O. Davidson. (2008). Diet-induced obesity and hepatic steatosis in L-Fabp / mice is abrogated with SF, but not PUFA, feeding and attenuated after cholesterol supplementation. American Journal of Physiology Gastrointestinal and Liver Physiology, 294(1), G307-314. DOI: 10.1152/ajpgi. 00377.2007
DOI
|
24 |
G. Siegenthaler, R. Hotz, D. Chatellard-Gruaz, L. Didierjean, U. Hellman, & J. H. Saurat. (1994). Purification and characterization of the human epidermal fatty acid-binding protein: localization during epidermal cell differentiation in vivo and in vitro. Biochemical Journal, 302(Pt 2), 363-371. DOI: 10.1042/bj3020363
DOI
|
25 |
D. A. Bernlohr, M. A. Simpson, A. V. Hertzel, & L. J. Banaszak. (1997). Intracellular lipid-binding proteins and their genes. Annual Review of Nutrition, 17, 277-303. DOI: 10.1146/annurev.nutr.17.1.277
DOI
|
26 |
J. amulin, I. Berget, S. Lien, & H. Sundvold. (2008). Differential gene expression of fatty acid binding proteins during porcine adipogenesis. Comparative Biochemistry and Physiology. Part B, Biochemical & Molecular Biolology, 151(2), 147-152. DOI: 10.1016/j.cbpb.2008. 06.010.
DOI
|
27 |
F. Guthmann, C. Schachtrup, A. Tolle, H. Wissel, B. Binas, H. Kondo, Y. Owada, F. Spener & B. Rustow. (2004). Phenotype of palmitic acid transport and of signalling in alveolar type II cells from E/H-FABP double-knockout mice: contribution of caveolin-1 and PPARgamma. Biochimca et Biophysica Acta, 1636(2-3), 196-204. DOI: 10.1016/j.bbalip.2003.10.015
DOI
|
28 |
J. Westerbacka, M. Kolak, T. Kiviluoto, P. Arkkila, J. Siren, A. Hamsten, R. M. Fisher & H. Yki-Jarvinen. (2007). Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes, 56(11), 2759-2765. DOI: 10.2337/db07-0156
DOI
|
29 |
Y. Owada, H. Takano, H. Yamanaka, H. Kobayashi, Y. Sugitani, Y. Tomioka, I. Suzuki, R. Suzuki, T. Terui, M. Mizugaki, H. Tagami, T. Noda & H. KONDO. (2002b). Altered water barrier function in epidermal-type fatty acid binding protein-deficient mice. The Journal of Investigative Dermatology, 118(3), 430-435. DOI: 10.1046/j.0022-202x.2001.01616.x
DOI
|
30 |
M. Hoekstra, M. Stitzinger, E. J. Van Wanrooij, I. N. Michon, J. K. Kruijt, J. Kamphorst, M. Van Eck, E. Vreugdenhil, T. J. Van Berkel & J. Kuiper. (2006). Microarray analysis indicates an important role for FABP5 and putative novel FABPs on a Western-type diet. Journal of Lipid Research, 47(10), 2198-2207. DOI: 10.1194/ jlr.M600095-JLR200
DOI
|
31 |
A. W. Thorburn, L. H. Storlien, A. B. Jenkins, S. Khouri & E. W. Kraegen. (1989). Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. The American Journal of Clinical Nutrition, 49(6), 1155-1163. DOI: 10.1093/ajcn/49.6.1155
DOI
|
32 |
S. R. Witting, M. Brown, R. Saxena, S. Nabinger & N. Morral. (2008). Helper-dependent Adenovirus-mediated Short Hairpin RNA Expression in the Liver Activates the Interferon Response. The Journal of Biological Chemistry, 283(4), 2120-2128. DOI: 10.1074/jbc.M704178200
DOI
|
33 |
K. A. Le & L. Tappy. (2006). Metabolic effects of fructose. Current Opinion in Clinical Nutrition and Metabolic Care, 9(4), 469-475. DOI: 10.1097/01.mco.0000232910.61612.4d
DOI
|
34 |
N. Morral, H. J. Edenberg, S. R. Witting, J. Altomonte, T. Chu & M. Brown. (2007). Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver. Journal of Lipid Research ,48(7), 1499-1510. DOI: 10.1194/jlr.M700090- JLR200
DOI
|